Clinical Trials on Healthy Volunteers Only in New Zealand

Total 1109 results

Arbor Pharmaceuticals, Inc.

Completed

A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human Volunteers

Healthy

United States
Pfizer

Completed

A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers

Healthy

United States
Pfizer

Completed

A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese Volunteers

Healthy

United States
FORUM Pharmaceuticals Inc

Completed

Study of EVP-6308 to Assess the Dose- and Concentration-dependent Displacement of [18F]MNI-659 by EVP-6308

Healthy

United States
Pfizer

Completed

A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865

Healthy

United States
Pfizer

Completed

A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects

Healthy

United States
Pfizer

Completed

First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects

Healthy

United States
Pfizer

Completed

A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562

Healthy

United States
Purdue Pharma LP

Completed

Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole

Healthy

United States
Bausch & Lomb Incorporated

Completed

A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)

Healthy

United States
Pfizer

Completed

A Study to Investigate the Effect of PH-797804 on QTc Interval

Healthy

United States
ViiV Healthcare
Pfizer

Completed

A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects

Healthy

United States
Pfizer

Terminated

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Healthy

United States
Puma Biotechnology, Inc.

Completed

A Single Dose Bioequivalence Study Of Neratinib In Healthy Subjects

Healthy

United States
GE Healthcare
Medpace, Inc.; i3 Statprobe

Completed

Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)

Healthy

United States
Pfizer

Terminated

A Single Dose Study Of PF-06291874 In Healthy Adult Subjects

Healthy

United States
Pfizer

Completed

Relative Drug Exposures Of Two Formulations of PF-02341066

Healthy

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Assess Blood Levels of Itraconazole During a Two-Week Period

Healthy

United States
Pfizer

Completed

Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects

Healthy

United States
Pfizer
Yale University

Completed

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers (3193A1-1103)

Healthy

United States
Pfizer

Terminated

To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers

Healthy

United States
Pfizer

Terminated

Evaluation Of PF-00572778 And Alprazolam On Naloxone Challenge In Healthy Subjects

Healthy

United States
Azevan Pharmaceuticals

Completed

Safety Study of SRX251 Capsules in Healthy Female Volunteers (AVN001)

Healthy

United States
Icahn School of Medicine at Mount Sinai
National Center for Complementary and Integrative Health (NCCIH)

Recruiting

Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP)

Healthy Control

United States
ElMindA Ltd

Completed

Normative Data of Brain Network Activation in Adolescents and Young Adults

Healthy Controls

United States
Pfizer

Recruiting

A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults

Healthy

United States
Sumitomo Pharma America, Inc.

Completed

Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654

Healthy

United States
Pranic Healing Research Institute

Completed

Changes in Microbiota in Healthy Subjects Before and After Meditation Practices in a Controlled Environment

Healthy

United States
Pfizer
Ono Pharmaceutical Co. Ltd; Pierre Fabre Laboratories

Completed

A Relative Bioavailability Study Evaluating Two New Encorafenib Formulations (ERBA)

Healthy

United States
KBP Biosciences

Completed

A Multiple Ascending Dose Study of KBP-7072 in Healthy Subjects

Healthy

United States
Pfizer
Arvinas Estrogen Receptor, Inc.

Completed

A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults

Healthy

United States
Eli Lilly and Company

Completed

A Study of LY3857210 in Healthy Participants

Healthy

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects

Healthy

United States
Yale University

Completed

Neuroimmune Response to Lipopolysaccharide

Healthy

United States
Topcon Medical Systems, Inc.

Completed

TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000

Healthy

United States
Cornell University

Completed

Safety of Graded-Dose of Histidine in Humans

Healthy

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study To Assess The Pharmacokinetics, Safety, And Tolerability Of A Pregabalin Controlled Release Formulation Administered Following Various Sized Caloric Meals As Compared To The Pregabalin Immediate Release Formulation

Healthy

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers

Healthy

United States
Pfizer

Completed

Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants

Healthy

United States
Pfizer

Completed

OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS

Healthy

United States
Biogen

Completed

A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects

Healthy

United States
Yale University

Terminated

Glycemic Index of Commonly Consumed Sweeteners

Healthy

United States
Pfizer

Completed

A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants

Healthy

United States
Pfizer

Completed

Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements

Healthy

United States
Pfizer

Completed

A Study To Evaluate The Effect Of PF-04447943 On Qtc Interval In Healthy Adult Subjects

Healthy

United States
Daiichi Sankyo, Inc.

Completed

Effects of CS-8080 in Healthy Volunteers

Healthy

United States
Daiichi Sankyo, Inc.

Terminated

Effects of Multiple Doses of CS-8080 in Healthy Volunteers

Healthy

United States
Janssen Research & Development, LLC

Completed

A Study to Investigate the Whole Body Distribution and Radiation Dosimetry of the Positron Emission Tomography Ligand Fluoride-18 (18F)-JNJ-64326067 in Healthy Participants

Healthy

United States
Pfizer

Completed

A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers

Healthy

United States
Pfizer

Completed

Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects

Healthy

United States

3

Subscribe